Brain Death
51
2
3
35
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.9%
3 terminated out of 51 trials
92.1%
+5.6% vs benchmark
8%
4 trials in Phase 3/4
11%
4 of 35 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 35 completed trials
Clinical Trials (51)
ORI and ETCO₂ Relationship With Arterial Blood Gas During Apnea Test
The Anticipated Organ Donation Approach
Non-Invasive Detection and Preservation of Neurocognitive Signals in the Peri-Death Period Using Brain-Computer Interface and Artificial Intelligence
Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)
Pupillometric Evaluation in Patients Declared Brain Dead - a Prospective Quality Control Study
Etiology and Hemodynamic Instability in Brain Death
Cyclosporine a Pretreatment and Kidney Graft Function
Rapid Reversal of CNS-Depressant Drug Effect Prior to Brain Death Determination
Determining ICU Staffs Conceptions, Opinions, Views, Experiences and Reflection of Brain Death and Organ Donation
Special Imaging Technique to Aid in the Diagnosis of Patients in Coma After Cardiac Arrest
Validation of the Apnea Test Performed by High-flow Oxygen Therapy in Patients With Clinical Brain Death
Implementation of Apnoea Test for Patients With Suspected Brain Death
The Use of Liraglutide in Brain Death
Electrical Impedance Tomography Measurements During Apnea Test in Patients With Suspected Brain Death
Orbital Artery Doppler Ultrasound in Brain Death
Intravenous Thyroxine for Heart-Eligible Organ Donors
Research on the Brain Death Determination in China
Incidence of Complications of Brain Death
Methods of Confirmation of Brain Death
Does Venous pCO2 Increase by 20 mmHg or More During Apnea Challenge Test?